GLP1-RAs may be a rational choice despite the highest price among the glucose-lowering medications, especially due to the renal and cardiovascular advantages discovered by the end of the study period, as mentioned above, but also because GLP1-RAs can promote weight loss and provide no risk of hypoglycaemia [18]. Here, GCG is linked to Hypoglycemia.